Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-02-07 @ 5:14 PM
Study NCT ID:
NCT05573802
Status:
RECRUITING
Last Update Posted:
2023-10-24
First Post:
2022-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Sponsor:
Hellenic Society of Hematology
Organization:
Conditions & Keywords Data
Conditions:
Keywords: